SYNOPSIS In chronic renal failure and after acute renal failure, fibrinogen levels are raised and there is diminished fibrinolysis as the result of renal damage. A similar situation is found in nephrosis, possibly due to fibrinolytic inhibitors.
Degradation products of fibrinogen and of fibrin are found in the sera of patients either with the defibrination syndrome or with excessive fibrinolysis. Excessive fibrinolysis may in certain states be a primary phenomenon but perhaps more commonly is a secondary reaction to the intravascular deposition of fibrin. Breakdown products may be detected by several immunological methods (Merskey, Kleiner, and Johnson, 1966 ).
The precise mechanism of acute renal failure is unknown: it is accepted that such patients have suffered renal ischaemia (Robson, 1966) . The important defect appears to be glomerular (Graber and Sevitt, 1959) as there is often little functional evidence of tubular damage. The average renal blood flow may be one-third of normal and yet the glomerular filtration rate only 1 % of normal. It is probably no mere coincidence that the list of causes of acute renal failure (Hardaway, 1966; McKay, 1965) is almost the same as the clinical causes of defibrination. The renal glomerulus is designed for filtration and it would not be surprising if unusually viscous material such as fibrin were to block the filters. Indeed, fibrin has now been demonstrated in the renal glomeruli by immunofluorescence in acute renal failure (Koffler and Paronetto, 1966) as well as in toxaemia of pregnancy (Vassalli, Morris, and McCluskey, 1965) and in acute glomerulonephritis and lupus nephritis (Vassalli and 'Now at Royal Victoria Infirmary, Newcastle upon Tyne 1. Received for publication 8 June 1967. McCluskey, 1965) . If fibrin breakdown products can be demonstrated in the circulation at the time of or shortly after the development of acute renal failure, then this is some indication that defibrination may be involved in the genesis of that condition. Better still would be the demonstration of the classical parameters of defibrination-hypofibrinogenaemia, thrombocytopenia, prolonged thrombin and silicone clotting times-as has been achieved in acute renal failure of obstetric origin (British Medical Journal editorial, 1965) . Unfortunately acute renal failure from other causes so often develops when the patient is at home or under circumstances in which all thought is directed to the associated shock. By the time that investigations are initiated the situation is complicated by the effect of renal damage on the bleeding and coagulation mechanism. Established uraemia may impair platelet function (Castaldi, Rozenberg, and Stewart, 1966) but it is not often the cause of thrombocytopenia. Fibrinolysis is impaired in chronic renal disease and fibrinogen levels are raised accordingly (Edward, Young, and Macleod, 1964; McNichol, Barakat, and Douglas, 1965) . In nephrosis the accompanying lipaemia has an antiplasmin effect and the X2 globulin fraction which is elevated has also antifibrinolytic activity. Reduced fibrinolysis and raised fibrinogen levels appear whenever there is renal damage as the kidney is the organ which produces plasminogen activator (Prokopowicz, Warowski, Poplawski, Gabryelewicz, and Niewiarowski, 1967 (Quick, 1951 (Alkjaersig, Fletcher, and Sherry, 1949 antihuman split fibrin serum. The original fibrin digest used to immunize the rabbit was prepared by plasmin digestion of human fibrinogen clotted by the addition of thrombin. The antiserum obtained gave precipitation lines with immunoglobulin G in addition to fibrin breakdown products but it was demonstrated that lines in the ,B region and one in the a region corresponded to major fibrin breakdown products ( Fig. 1 ). In this investigation we have concentrated upon the significance of the fibrin breakdown products seen in the ft region.
PIBRIN DEGRADATION PRODUCTS These were also assayed quantitatively using the tanned-red cell haemagglutination inhibition technique of Merskey et al. (1966) . Doubling dilutions of serum were used up to a titre of 1/512, which, it was estimated,correspondsto 320 micrograms fibrin degradation products per ml. Significant titres were taken to be those over 1:32 corresponding to 20 micrograms fibrin degradation products per ml.
CLINICAL MATERIAL
Immunoelectrophoresis of serum and the tanned-red-cell test for fibrin breakdown products were performed on sera from various patients admitted to the haematological and renal beds. Seventy-two cases of renal disease, including 20 cases of acute renal failure, were studied in this way and 20 normal persons and 28 patients with various disorders. Studies on the coagulation and fibrinolytic mechanism were made on over a hundred patients in the same beds. For various reasons it was not always possible to perform the complete series of tests on each individual. All were studied as near as possible to the acute phase of their disease. In the case of acute renal failure the time was usually one to four days after the onset. None had had haemodialysis: some had had peritoneal dialysis. Table I summarizes the results for the estimation of plasma fibrinogen, cryofibrinogen (heparin), and for plasminogen. The normal fibrinogen levels were 130-410 mg% with a mean of 285 mg%. The mean Figure 2 deals specifically with the data obtained in the cases of acute renal failure. It shows that at the time of examination, some one to four days after the onset, fibrinogen levels are raised, as also may be cryofibrinogen levels, and about half of the cases have low platelet counts. In five of 13 cases the thrombin times were prolonged. Moreover, at this time fibrinolysis is depressed as shown by prolongation of euglobulin lysis times and normal and slightly elevated plasminogen levels. Only two cases had low plasminogen levels and rapid euglobulin lysis: these were a case of A.P.H. examined at the fourth day and a case of post-prostatectomy anuria examined at the tenth day. found in the cases of acute renal failure and also in shock. Figure 4 shows for the cases of acute renal failure and of shock the time after the onset at which fibrin degradation products were found in the circulation. It will be seen that on average such products were found in the oliguric patient for up to four days after the onset. The cases of shock alone were seen early. Serum taken from a case of cardiac arrest half an hour after the event gave a negative result for fibrin degradation products, but incidentally there was at that time a hypofibrinogenaemia of 90 mg %, and two hours later when the man was still unconscious and shocked fibrin degradation products were present. Table III gives the aetiology of the types of (Koller, 1964) . Whereas hypofibrinogenaemia with cryofibrinogenaemia, thrombocytopenia, a low prothrombin, and clotting factor depletion indicate defibrination, yet in a pure fibrinolytic state the platelets are normal, the prothrombin is normal, and cryofibrinogen is not found but of course euglobulin lysis is accelerated and plasminogen levels are low. It is very likely that because patients who are victims of a defibrination syndrome can be critically ill, often in shock, with the exception of obstetric cases, they are not investigated at this appropriate early stage and indeed not until fibrinogen levels are restored and there is secondary fibrinolysis. Hardaway has shown in the dog that the liver can restore fibrinogen to the extent of 50mg% per hour (Hardaway, 1966 (1965) and with that of Edward et al. (1964) and are the direct result of renal damage. However, an important difference noted here is the raised plasminogen levels found in nephrosis, whereas each of the mentioned groups of workers found some low plasminogen values in the nephrotic syndrome. The explanation may lie in the aetiology of the nephrosis, in the form of therapy-steroids or not-or in the degree of azotaemia of the patients. The finding of high plasminogen values in nephrosis is more in accordance with diminished fibrinolytic activity and is probably due in this case to an ax-globulin inhibitor of plasmin.
RESULTS
Cryofibrinogen does not merely reflect a raised plasma fibrinogen level (McKee, Kalbfleisch, and Bird, 1963) , but being the first product in the degradation of fibrinogen (MacFarlane, 1964) , it is an indicator of intravascular coagulation (Glueck and Herrmann, 1964) , although it is also found when there is extravascular fibrin deposition as in rheumatic fever and rheumatoid disease. The fact that it was found to be raised in various unselected cases of renal disease is of importance. Had all cases been selected in the acute phase, the results might have been even more striking. It should be recalled that McKay and Corey (1964) found cryofibrinogen to be raised in toxaemia of pregnancy, which is thought to be a chronic state of intravascular coagulation (McKay, 1964) . In the case of nephrosis it might be postulated that cryofibrinogen is formed because of the action on platelets of circulating antigen-antibody complexes (Robbins and Stetson, 1959) , which as Dixon, Feldman, and Vazquez (1961) have shown, can produce in the experimental animal the spectrum of human glomerulonephritis.
Care must be exercised in the interpretation of the results of the immunoelectophoresis. Are these products the result of primary intravascular coagulation or merely of fibrinolysis? As shown here, fibrinolysis is reduced in uraemia, but in individual cases of acute renal failure it can be excessive. Nevertheless, in these cases, with the exception of pancreatitis and the post-prostatectomy state, fibrinolysis is probably secondary to intravascular coagulation. Whichever mechanism is operative, it is clear that in shock or in acute renal failure fibrinogen has been converted to fibrin and to its degradation products.
It has been shown, therefore, that in chronic renal disease and after acute renal failure there is reduced fibrinolysis with prolonged euglobulin lysis times and normal or slightly elevated plasminogen values. The group of patients with acute renal failure show evidence of low platelet counts, impaired thrombin time, raised cryofibrinogen values and the appearance of fibrin degradation products, all of which can be interpreted as corroborative evidence of intravascular coagulation. At this late stage after the onset, raised fibrinogen levels are to be expected. Deposition of fibrin in the renal glomeruli may lead to reduced filtration and be a factor in the production of anuria. Deposition of fibrin in the renal vasculature will, if present for only hours, lead to ischaemic necrosis of tubular cells. In this respect the high fibrinolytic activity of the kidney due to its plasminogen activator content can be seen in a protective role (Januszko, Furman, and Buluk, 1966) (Kwaan, and Fischer, 1965) and will account for the fact that late biopsies show no evidence of fibrin or thrombi.
